Clinical Trial Update: Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial of donepezil completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction
• Memory Impairment

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Cognitive Dysfunction, Memory Impairment | Phase 3 | Status: COMPLETED | Results posted: 2023-09-13